OrbiMed’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,868,786
| Closed | -$28.7M | – | 165 |
|
|
2021
Q4 | $28.7M | Sell |
3,868,786
-11,029,128
| -74% | -$81.8M | 0.37% | 67 |
|
|
2021
Q3 | $84.5M | Buy |
14,897,914
+1,961,292
| +15% | +$11.1M | 0.93% | 32 |
|
|
2021
Q2 | $85.3M | Buy |
12,936,622
+3,804,800
| +42% | +$25.1M | 0.86% | 38 |
|
|
2021
Q1 | $74M | Buy |
9,131,822
+6,577,922
| +258% | +$53.3M | 0.69% | 44 |
|
|
2020
Q4 | $16.5M | Buy |
+2,553,900
| New | +$16.5M | 0.14% | 110 |
|
|
2020
Q1 | – | Sell |
-286,800
| Closed | -$1.46M | – | 161 |
|
|
2019
Q4 | $1.46M | Buy |
+286,800
| New | +$1.46M | 0.02% | 120 |
|
|
2018
Q4 | – | Sell |
-1,469,189
| Closed | -$13.9M | – | 147 |
|
|
2018
Q3 | $13.9M | Sell |
1,469,189
-1,435,081
| -49% | -$13.6M | 0.17% | 99 |
|
|
2018
Q2 | $28.3M | Buy |
2,904,270
+1,400,000
| +93% | +$13.6M | 0.34% | 70 |
|
|
2018
Q1 | $15.8M | Sell |
1,504,270
-1,329,856
| -47% | -$14M | 0.2% | 89 |
|
|
2017
Q4 | $18.2M | Sell |
2,834,126
-2,616,455
| -48% | -$16.8M | 0.23% | 81 |
|
|
2017
Q3 | $41.7M | Buy |
5,450,581
+1,512,309
| +38% | +$11.6M | 0.4% | 68 |
|
|
2017
Q2 | $28M | Sell |
3,938,272
-2,157,375
| -35% | -$15.3M | 0.29% | 73 |
|
|
2017
Q1 | $23.6M | Hold |
6,095,647
| – | – | 0.27% | 74 |
|
|
2016
Q4 | $12.4M | Hold |
6,095,647
| – | – | 0.16% | 80 |
|
|
2016
Q3 | $16.3M | Hold |
6,095,647
| – | – | 0.19% | 79 |
|
|
2016
Q2 | $18.8M | Hold |
6,095,647
| – | – | 0.2% | 72 |
|
|
2016
Q1 | $51.9M | Hold |
6,095,647
| – | – | 0.55% | 45 |
|
|
2015
Q4 | $82.7M | Buy |
6,095,647
+2,501,647
| +70% | +$33.9M | 0.75% | 41 |
|
|
2015
Q3 | $34.5M | Buy |
3,594,000
+2,564,000
| +249% | +$24.6M | 0.35% | 56 |
|
|
2015
Q2 | $14.8M | Buy |
+1,030,000
| New | +$14.8M | 0.12% | 89 |
|